FDA Clearance Tracker · P220021
DETOUR System
Last checked: Nov 20, 2026Latest source record: Jun 7, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 7, 2023
Approved
Time to decision
239 days
Received Oct 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P220021
- Device name
- DETOUR System
- Applicant
- Endologix, LLC
- Applicant location
- Santa Rosa, CA
- Received
- Oct 11, 2022
- Decided
- Jun 7, 2023
- Decision
- Approved
- Supplements
- 9 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the DETOUR System for use for percutaneous revascularization in patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis >70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments. The DETOUR System, or any of its components, is not for use in the coronary and cerebral vasculature.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QWM (Stent graft, bypass, superficial femoral artery).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Endologix, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Alto Abdominal Stent Graft SystemPMA supplement
P120006-S031 · Decided Mar 13, 2020 · 366 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.